Could This Be Eli Lilly's Next Blockbuster Drug?

Could This Be Eli Lilly's Next Blockbuster Drug?

Source: 
Motley Fool
snippet: 
  • Mirikizumab could be used by tens of thousands of patients if approved by the U.S. Food and Drug Administration.
  • An ulcerative colitis indication could generate $800 million in annual sales for Eli Lilly in the U.S. alone.
  • Eli Lilly still looks like it could be a buy for growth investors.